JP2024536358A5 - - Google Patents
Info
- Publication number
- JP2024536358A5 JP2024536358A5 JP2024520682A JP2024520682A JP2024536358A5 JP 2024536358 A5 JP2024536358 A5 JP 2024536358A5 JP 2024520682 A JP2024520682 A JP 2024520682A JP 2024520682 A JP2024520682 A JP 2024520682A JP 2024536358 A5 JP2024536358 A5 JP 2024536358A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- light chain
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110881474.1 | 2021-08-02 | ||
| CN202110881474 | 2021-08-02 | ||
| PCT/CN2022/108881 WO2023011338A1 (zh) | 2021-08-02 | 2022-07-29 | 抗CD79b×CD3双特异性抗体及其用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024536358A JP2024536358A (ja) | 2024-10-04 |
| JP2024536358A5 true JP2024536358A5 (cg-RX-API-DMAC7.html) | 2025-08-06 |
Family
ID=85154284
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024520682A Pending JP2024536358A (ja) | 2021-08-02 | 2022-07-29 | 抗cd79b×cd3二重特異性抗体及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240343799A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4382538A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024536358A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117897404A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022324406B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3231174A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023011338A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118667023B (zh) * | 2024-07-16 | 2025-07-15 | 上海生物制品研究所有限责任公司 | 一种抗ox40抗体及其制备方法和应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・2・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| AU691811B2 (en) | 1993-06-16 | 1998-05-28 | Celltech Therapeutics Limited | Antibodies |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US6194551B1 (en) | 1998-04-02 | 2001-02-27 | Genentech, Inc. | Polypeptide variants |
| CA2323757C (en) | 1998-04-02 | 2011-08-02 | Genentech, Inc. | Antibody variants and fragments thereof |
| HUP0104865A3 (en) | 1999-01-15 | 2004-07-28 | Genentech Inc | Polypeptide variants with altered effector function |
| US6737056B1 (en) | 1999-01-15 | 2004-05-18 | Genentech, Inc. | Polypeptide variants with altered effector function |
| HUE035898T2 (en) | 2002-12-16 | 2018-05-28 | Genentech Inc | Immunoglobulin variants and their applications |
| TR201808537T4 (tr) | 2004-09-23 | 2018-07-23 | Genentech Inc | Sistein değiştirilmiş antikorlar ve konjugatlar. |
| PE20140625A1 (es) * | 2007-07-16 | 2014-05-29 | Genentech Inc | ANTICUERPOS ANTI-CD79b E INMUNOCONJUGADOS HUMANIZADOS |
| MX386587B (es) * | 2014-12-05 | 2025-03-19 | Genentech Inc | ANTICUERPOS ANTI-CD79b Y MÉTODOS DE USO. |
| WO2017177337A1 (en) * | 2016-04-15 | 2017-10-19 | Zymeworks Inc. | Multi-specific antigen-binding constructs targeting immunotherapeutics |
| US20190322741A1 (en) * | 2016-06-07 | 2019-10-24 | Macrogenics, Inc. | Methods for the Use of CD32B x CD79B-Binding Molecules in the Treatment of Inflammatory Diseases and Disorders |
| JP2022513338A (ja) * | 2018-10-03 | 2022-02-07 | ネペンザ・バイオサイエンシズ・エルエルシー | 抗cd79抗体およびその使用 |
| TWI841790B (zh) * | 2019-09-30 | 2024-05-11 | 大陸商和鉑醫藥(上海)有限責任公司 | 靶向cd3的抗體、雙特異性抗體及其用途 |
| CR20220166A (es) * | 2019-10-18 | 2022-06-15 | Genentech Inc | Métodos para usar inmunoconjugados anti-cd79b para tratar linfoma difuso de linfocitos b grandes |
| WO2022068809A1 (zh) * | 2020-09-29 | 2022-04-07 | 信达生物制药(苏州)有限公司 | 抗cd3抗体以及其用途 |
-
2022
- 2022-07-29 CA CA3231174A patent/CA3231174A1/en active Pending
- 2022-07-29 WO PCT/CN2022/108881 patent/WO2023011338A1/zh not_active Ceased
- 2022-07-29 EP EP22852051.6A patent/EP4382538A4/en active Pending
- 2022-07-29 AU AU2022324406A patent/AU2022324406B2/en active Active
- 2022-07-29 CN CN202280053838.XA patent/CN117897404A/zh active Pending
- 2022-07-29 US US18/294,212 patent/US20240343799A1/en active Pending
- 2022-07-29 JP JP2024520682A patent/JP2024536358A/ja active Pending